Document is current
Any future updates will be listed below
-
Authors
Schaefer-Babajew, Dennis https://orcid.org/0000-0002-5380-2950
Wang, Zijun https://orcid.org/0000-0002-2095-2151
Muecksch, Frauke https://orcid.org/0000-0002-0132-5101
Cho, Alice https://orcid.org/0000-0001-6354-6148
Loewe, Maximilian https://orcid.org/0000-0003-2935-3750
Cipolla, Melissa
Raspe, Raphael https://orcid.org/0000-0003-3409-4968
Johnson, Brianna https://orcid.org/0000-0003-3214-284X
Canis, Marie
DaSilva, Justin
Ramos, Victor
Turroja, Martina https://orcid.org/0000-0001-9640-0559
Millard, Katrina G. https://orcid.org/0000-0003-2247-3178
Schmidt, Fabian
Witte, Leander https://orcid.org/0000-0002-4704-8461
Dizon, Juan
Shimeliovich, Irina
Yao, Kai-Hui
Oliveira, Thiago Y. https://orcid.org/0000-0002-2654-0879
Gazumyan, Anna
Gaebler, Christian https://orcid.org/0000-0001-7295-8128
Bieniasz, Paul D. https://orcid.org/0000-0002-2368-3719
Hatziioannou, Theodora https://orcid.org/0000-0002-7889-0766
Caskey, Marina https://orcid.org/0000-0003-1727-8693
Nussenzweig, Michel C. https://orcid.org/0000-0003-0592-8564
- License Information
-
More Information
Article History
Received: 4 June 2022
Accepted: 30 November 2022
First Online: 6 December 2022
Competing interests
: The Rockefeller University has filed a provisional patent application in connection with this work, on which M.C.N. is listed as an inventor (US patent 63/021,387). The patent has been licensed by Rockefeller University to Bristol Meyers Squib. P.D.B. has received remuneration from Pfizer for consulting services related to SARS-CoV-2 vaccines.
